Skip to Content

Revance Therapeutics

Revance’s therapeutic pipeline seeks to bring innovation to multiple indications in muscle movement and pain disorders.

Therapeutics

FACTS, FIGURES, & TRENDS

$2.3 billion

Estimated global sales of neurotoxin for therapeutic use.1

12

Approved therapeutic indications for botulinum toxin Type A in the U.S. and hundreds of potential indications.2

3

Ongoing clinical trials for therapeutic indications of DaxibotulinumtoxinA for Injection.3,4,5

DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.

Daring to Make a Difference in Therapeutics

Revance is currently evaluating DaxibotulinumtoxinA for Injection in therapeutic indications, including cervical dystonia (Phase 3), upper limb spasticity (Phase 2), and plantar fasciitis (Phase 2), with plans to study migraine. The topline results are anticipated in the second half of 2020 for the cervical dystonia and plantar fasciitis trials.

For the latest information regarding our clinical development programs, please see our public filings with Securities and Exchange Commissions or visit www.clinicaltrials.gov

Publications

DaxibotulinumtoxinA for Injection is an investigational product. It is currently undergoing clinical studies for both therapeutic and aesthetic indications.

Clinical Highlights

References

  1. 2019 (E) based on Decision Resources Group Therapeutic Botulinum Toxin Market Analysis Global 2019, November 2018 and Decision Resources Group Aesthetics Injectables Botulinum Toxin Reports, December 2019 and December 2020

  2. Time Magazine, January 16, 2017, How BOTOX Became the Drug That’s Treating Everything. Available at: https://time.com/4623409/botox-drug-treating-everything/. Accessed April 2020

  3. Clinicaltrials.gov. US National Library of Medicine. Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity (JUNIPER). Available at: https://clinicaltrials.gov/ct2/show/NCT03821402. Accessed July 2019.

  4. Clinicaltrials.gov. US National Library of Medicine. Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (ASPEN-1) Available at: https://clinicaltrials.gov/ct2/show/NCT03608397. Accessed July 2019.

  5. Clinicaltrials.gov. US National Library of Medicine. DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis. Available at: https://clinicaltrials.gov/ct2/show/NCT03825315. Accessed July 2019.

Career Opportunities

Do you have what it takes to join our team? Check out our Careers page and find out.

Learn More
Back to top